Introduction
Anti-neutrophil cytoplasmic autoantibodies (ANCA),
In contrast to the systemic vasculitides, in which directed against cytoplasmic constituents of neutro-ANCA titres are related to disease activity,10 conphil granulocytes, have originally been detected in flicting results have been reported on the relation sera from patients with systemic vasculitides, in between ANCA and clinical expression of inflammatparticular Wegener's granulomatosis.1 Their diaory bowel disease. In ulcerative colitis, ANCA titres gnostic significance in these disorders has been well were reported to correlate with disease activity.4,5 established. The elucidation of the target antigens of Furthermore, ANCA-positive patients were found to ANCA in the vasculitides, proteinase 3 and myelohave a more refractory type of disease than ANCAperoxidase, has further increased their diagnostic negative patients.11,12 In Crohn's disease, ANCA have value.2 been suggested to be markers for colonic involve-ANCA have also been detected in serum samples ment. 13 However, many other studies failed to detect from 50-80% of patients with ulcerative colitis and clinical differences between ANCA-positive and 10-20% of patients with Crohn's disease.3,4 ANCA ANCA-negative patients in both ulcerative colitis and in inflammatory bowel disease are directed against
Crohn's disease.3,14-16 Very few studies have used a wide variety of antigens, including lactoferrin,5,6 serial samples to investigate the relation between bactericidal/permeability-increasing protein,7,8 and the cytosolic antigens catalase and a-enolase.9
ANCA and disease activity.17
To elucidate the relation between ANCA titre and degree). A score >4 was considered as active disease. For Crohn's disease, disease activity was disease activity, we analysed the presence and titre of ANCA in paired samples from patients with measured using the Spearman rank correlation test. For analysis of serial having quiescent disease at entry, a second plasma samples, correlations between disease activity and sample was analysed obtained during an active ANCA titre were determined using the Spearman phase of the disease (group II). If a patient was rank correlation test in each patient. The mean classified as having active (group III) or quiescent correlation coefficient was calculated after (group IV) disease during the total observation period, Z-transformation. A p value <0.05 was considered a second plasma sample was analysed that was significant for all tests. obtained at a random second time point during the observation period with an interval of at least one month from the first sample.
Results
To analyse more accurately possible fluctuations of ANCA with time in relation to disease activity, at Ulcerative colitis least four serial samples were obtained from 21 unselected patients with ulcerative colitis and 26
Sixty patients with ulcerative colitis were included in this study. Thirty-eight (63%) patients had at least with Crohn's disease, a subset of the total group. All plasma samples were stored at −20°C until ANCA one sample included that was positive for ANCA. All positive samples showed perinuclear (pANCA) testing.
For ulcerative colitis, disease activity was measstaining, with the exception of one sample with cytoplasmic staining. The presence of ANCA was ured using a clinical activity score. This score is based on the presence and intensity of eight key not related to sex, age, duration of the disease, localization of the disease, or use of immunosuppressymptoms of ulcerative colitis, i.e. blood loss, mucoid discharge, frequency of defaecation, consistency of sive medication (corticosteroids, azathioprine, or both). Previous bowel resection did not influence faeces, tenesmus, abdominal pain, rectal pain, and nausea/vomiting. Each symptom is scored from 0 to the presence of ANCA: eight patients had undergone bowel resection, of whom four (50%) were positive 2, resulting in a total score ranging from 0 (no symptoms) to 16 (all symptoms present, most severe for ANCA, whereas 30/52 (58%) patients without previous bowel resection were positive for ANCA disease activity status in groups I and II were not related to changes in ANCA titre. Changes in ANCA ( p=0.72; Fisher's exact test).
titre between the first and the second sample were
Paired samples from patients with ulcerative
also observed in group IV, in which the disease was colitis persistently quiescent during the total observation period. The use of immunosuppressive medication To determine any correlation between ANCA titre did not influence the presence or titre of ANCA. and disease activity in individual patients, pairs of samples from the 60 patients were analysed. Patients
Serial samples from patients with ulcerative
were divided into four different groups based on the colitis course of disease activity during the study period, as stated in the methods section. Thirteen patients were
To study the fluctuation of ANCA titres with time in relation to disease activity, we analysed ANCA titre in group I (active-quiescent), 14 were in group II (quiescent-active), six were in group III (activeand disease activity in serial samples from 21 ulcerative colitis patients who had at least four (median 6, active), and 27 were in group IV (quiescentquiescent). Clinical characteristics of the four groups range 4-11) samples included in the study. Mean (median) follow-up period was 24.6 (24) months of patients are given in Table 1. ANCA prevalence was not different between the (range 12-42 months). Fifteen of these 21 patients were at least once four groups (Table 1 ). Figure 1 shows the individual paired ANCA titres in the four groups. Changes in positive for ANCA during the observation period. Two patients had persistently active disease during activity was measured with the Van Hees index. Since the correlation between the two indices was the total observation period (one ANCA-positive and one ANCA-negative). Three patients had persistently low in this study (r=0.38; p<0.001; Spearman rank correlation test), we separately analysed the relation quiescent disease during the total observation period (two ANCA-positive and one ANCA-negative). The between clinical disease activity (Harvey-Bradshaw index) and ANCA titres and that between inflammatremaining 16 patients had intermittently active disease (twelve ANCA-positive and four ANCAory activity (Van Hees index) and ANCA titres. negative).
There Crohn's disease index. Twenty patients were in group I (activequiescent), 18 were in group II (quiescent-active), In this study, 101 patients with Crohn's disease were included. Twenty-one (21%) patients had at least six were in group III (active-active), and 57 were in group IV (quiescent-quiescent). Clinical characterone sample included that was positive for ANCA. Samples from 17 patients showed perinuclear istics of the four groups are given in Table 2 . ANCA prevalence was not different between the (pANCA) staining, whereas samples from the other four patients showed cytoplasmic staining. The presfour groups. Figure 3 shows the individual paired ANCA titres in the four groups. Changes in disease ence of ANCA was not related to sex, age, duration of the disease, localization of the disease, or use of activity status in groups I and II were not related to changes in ANCA titre. Changes in ANCA titre were immunosuppressive medication. Previous bowel resection did not influence the presence of ANCA: also observed in groups III and IV, in which the disease was either persistently active or persistently 54 patients had undergone bowel resection, of whom seven (13%) were positive for ANCA, whereas 10/47 quiescent during the total observation period. The use of immunosuppressive medication did not influ-(21%) patients without previous bowel resection were positive for ANCA ( p=0.30; Fisher's exact ence the presence or titre of ANCA. Likewise, ANCA prevalence and titre were not related to inflammatory test).
Clinical disease activity was measured with the disease activity as assessed by the Van Hees index (data not shown). Harvey-Bradshaw index. In addition, inflammatory 
Serial samples from patients with Crohn's
Clinical and inflammatory disease activity and ANCA disease titres during follow-up in these six patients are shown To study the fluctuation of ANCA titres over time in in Figure 4 . relation to clinical and inflammatory disease activity, we analysed ANCA and disease activity in serial samples from 26 Crohn's disease patients who had Discussion at least 4 (median 6, range 4-11) samples included in the study. Mean (median) follow-up period was
In this study, we demonstrated that in patients with inflammatory bowel disease, ANCA titres do not 29.1 (29) months (range 7-43 months).
Six of these 26 patients were at least at one correlate with disease activity. In the ANCA-associated vasculitides, several studies have shown a occasion positive for ANCA during the observation period. Nine patients had clinically quiescent disease relation between disease activity and ANCA titre (reviewed in reference 10). In these diseases, ANCA during the total observation period (one ANCApositive and eight ANCA-negative). The remaining become often undetectable after starting immunosuppressive treatment. Relapses frequently occur in 17 patients had intermittently active disease (five ANCA-positive and 12 ANCA-negative). There was patients being persistently positive for ANCA or in whom ANCA reappear. that treatment with immunosuppressive medication their different approaches to disease activity, neither index correlated with ANCA titres. based on rises in ANCA titre prevented the occurrence of relapses in patients with Wegener's granuloWe used two different approaches to analyse the relation between disease activity and ANCA titre. matosis. Thus, serial measurement of ANCA titres may be useful for follow-up and treatment of patients First, we determined ANCA titres in paired samples from groups of patients who were discordant in their with ANCA-associated vasculitides.
However, in inflammatory bowel disease, the course of disease activity. Changes in ANCA titre were found in a significant number of paired samples, relation between disease activity and ANCA titre has been less clear. In ulcerative colitis, several studies with no correlation with changes in disease activity. Changes in ANCA titre were also observed in patients reported that high titres of ANCA were particularly found in patients with active disease,29-31 but other with either persistently active or persistently quiescent disease. Conversions from ANCA-negative to studies failed to detect a relation between disease activity and ANCA titre.3,32 However, these were all ANCA-positive and vice versa were detected without any relation to disease activity. Secondly, since cross-sectional studies. No large studies investigating a possible relation between disease activity and paired samples may not precisely reflect the course of ANCA titre changes in time, we determined ANCA ANCA titres in individual patients have been performed thus far. The single long-term observation of titres in serial samples during a long-term observation period. In agreement with the results obtained with ANCA in ulcerative colitis published until now only reported the presence or absence of ANCA and did paired samples, we found no correlation between disease activity and ANCA titres in these serial not study whether titres varied with disease activity. 17 The data reported here clearly show that disease samples. The use of immunosuppressive medication had no influence on the presence or titre of ANCA activity of both ulcerative colitis and Crohn's disease are not related to ANCA titres. For measurement of in the paired and serial samples from patients with ulcerative colitis or Crohn's disease. disease activity of ulcerative colitis, we have used an index that has been developed to evaluate disease An important difference between the findings in the vasculitides and in the inflammatory bowel activity in clinical trials and is widely used in The Netherlands. For Crohn's disease, two different diseases is that ANCA in the vasculitides, in contrast to ANCA in inflammatory bowel disease, are usually indices were used to measure disease activity: the Harvey-Bradshaw index which measures clinical disdirected against one single antigen. Antibodies to proteinase 3 are highly specific for Wegener's granulease activity, scoring of which is, to some extent, subject to clinical interpretation; and the Van Hees omatosis, whereas antibodies to myeloperoxidase are associated with microscopic polyangiitis, the Churgindex, mainly based on inflammatory parameters as measured in the laboratory. Although these indices Strauss Syndrome, or idiopathic necrotizing crescentic glomerulonephritis.2 ANCA in inflammatory were not concordant, which might be explained by bowel disease are directed against a wide variety of inflammatory bowel disease does not contribute to the monitoring of the disease process and thus to a antigens, including lactoferrin,5,6 bactericidal/permeability-increasing protein,7,8 several nuclear antibetter treatment. gens,33,34 and several cytosolic antigens.9 In addition, antibodies to various antigenic specificities may be present in one serum sample. We9,35 and others36,37 serial measurement of ANCA titres in patients with
